CHAPTER 1 - MARKET SUMMARY
Market Overview
The Australia Medical Imaging Market operates through capital-equipment procurement, replacement cycles, software upgrades, maintenance contracts and hospital or outpatient imaging investment. Australia recorded around 30.0 million Medicare-subsidised diagnostic imaging services in 2024-25, demonstrating a large recurring clinical workload. High scan volumes improve equipment utilisation and sustain demand for CT, MRI, ultrasound and digital radiography upgrades.
Demand is concentrated in New South Wales, Victoria and Queensland, where population density, tertiary hospitals and private diagnostic networks support the deepest installed base. Nationally, Australia had 94 CT, MRI and PET scanners per million population in 2023 or nearest year, versus an OECD average of 51. This equipment intensity makes replacement and productivity-led upgrades commercially important.
Market Value
USD 1,030 million
2025
Dominant Region
New South Wales
Dominant Segment
Computed Tomography Systems
fastest growing major modality
Total Number of Players
52
Future Outlook
The Australia Medical Imaging Market is forecast to expand from USD 1,030 million in 2025 to USD 1,569 million by 2032, representing a 6.20% forecast CAGR. This compares with an estimated 5.72% historical CAGR during 2020-2025. The growth profile reflects equipment replacement, increasing scan intensity, broader MRI reimbursement eligibility and demand for higher-throughput platforms. CT, MRI and ultrasound procurement should increasingly incorporate AI reconstruction, automated positioning and workflow software. Value growth is expected to remain moderately above physical system-volume growth because premium platforms, software subscriptions, detector upgrades and multi-year service agreements increase revenue per installed system.
By 2032, procurement economics are expected to shift toward lifecycle productivity rather than equipment acquisition price alone. Photon-counting and spectral CT, low-helium MRI, portable imaging and AI-assisted workflow tools can improve throughput while reducing repeat scans and technician workload. Australia already operates an imaging-equipment density materially above the OECD average, making replacement demand more important than first-time modality penetration in metropolitan markets. Regional locations retain capacity whitespace, supported by reimbursement reform and public investment. The principal constraint will be skilled workforce availability, particularly radiographers and sonographers, which increases the strategic value of automation, remote support, managed-equipment arrangements and productivity-enhancing software.
6.20%
Forecast CAGR
$1,569 Mn
2030 Projection
Base Year
2025
Historical Period
2020-2025
Forecast Period
2025-2032
Historical CAGR
5.72%
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, replacement cycle, recurring service revenue, consolidation, ROI
Corporates
modality demand, tender pipeline, pricing, installed base, upgrades
Government
imaging access, reimbursement, workforce, regulation, regional capacity
Operators
scanner utilization, throughput, staffing, uptime, lifecycle economics
Financial institutions
equipment finance, cash flow, utilization, residual values, covenants
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020-2025)
Market expansion accelerated after the pandemic-era disruption as deferred equipment replacement, higher examination volumes and hospital capital programs returned. The strongest annual increase occurred in 2025 at 6.30%, following 6.28% in 2023. Australia also experienced more than a 50% increase in CT examination rates between 2013 and 2023, according to OECD analysis, reinforcing the structural utilisation case for higher-throughput systems. Increased private diagnostic-network investment and digital detector replacement supported radiography and ultrasound demand alongside advanced modalities.
Forecast Market Outlook (2025-2032)
The market is projected to deliver a 6.20% CAGR through 2032. Growth is expected to be led by premium CT, MRI, portable ultrasound and software-enabled equipment rather than basic system additions alone. Lifecycle revenue should increase as hospitals procure AI reconstruction, cybersecurity upgrades and longer service agreements alongside hardware. Reimbursement liberalisation for MRI lowers utilisation barriers, while the transition toward photon-counting CT and automated scanning lifts average equipment value. Volume growth remains below value growth as product mix shifts toward higher-specification platforms and digitally enabled upgrade packages.
CHAPTER 5 - Market Data
Market Breakdown
The Australia Medical Imaging Market is moving from a predominantly hardware-replacement cycle toward a combination of modality upgrades, AI-supported workflow and service-intensive procurement. The KPI series below combines market values with internally reconciled operating indices used to evaluate replacement intensity, technology mix and equipment demand.
Year | Market Size (USD Mn) | YoY Growth (%) | Major Imaging System Shipment Index (2025=100) | Replacement Demand Share (%) | AI-Enabled New System Share (%) | Period |
|---|---|---|---|---|---|---|
| 2020 | $780 Mn | +- | 78 | 52% | Forecast | |
| 2021 | $815 Mn | +4.49% | 82 | 53% | Forecast | |
| 2022 | $860 Mn | +5.52% | 87 | 54% | Forecast | |
| 2023 | $914 Mn | +6.28% | 92 | 55% | Forecast | |
| 2024 | $969 Mn | +6.02% | 96 | 56% | Forecast | |
| 2025 | $1,030 Mn | +6.30% | 100 | 57% | Forecast | |
| 2026 | $1,095 Mn | +6.31% | 105 | 58% | Forecast | |
| 2027 | $1,165 Mn | +6.39% | 110 | 59% | Forecast | |
| 2028 | $1,238 Mn | +6.27% | 116 | 60% | Forecast | |
| 2029 | $1,315 Mn | +6.22% | 122 | 61% | Forecast | |
| 2030 | $1,397 Mn | +6.24% | 128 | 62% | Forecast | |
| 2031 | $1,482 Mn | +6.08% | 134 | 63% | Forecast | |
| 2032 | $1,569 Mn | +5.87% | 140 | 64% | Forecast |
Major Imaging System Shipment Index
100 (2025, Australia). Replacement and capacity additions are supported by sustained scan volumes. More than 27 million Medicare-subsidised diagnostic imaging services were delivered in 2022-23, demonstrating a large installed-base workload.
Replacement Demand Share
57% (2025, Australia model). Australia's high equipment density makes replacement economics central to procurement. The country records 94 CT, MRI and PET scanners per million population compared with an OECD average of 51.
AI-Enabled New System Share
50% (2025, Australia model). AI increasingly enters reconstruction, triage and workflow layers. The TGA maintains a dedicated list of AI-enabled medical devices in the ARTG, updated through July 2026.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Product Type
Fastest Growing Segment
Technology
Product Type
Care Setting
End User
Disease Area
Channel
Technology
Geography
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Product Type
Product mix remains the strongest revenue-allocation axis because CT, MRI, ultrasound, radiography and molecular-imaging platforms have materially different capital costs, replacement cycles and service economics. Ionising imaging systems represent the broadest installed equipment pool, while CT contributes an important premium revenue component as providers prioritize faster acquisition, dose reduction and spectral capability.
Technology
Technology is the fastest-changing strategic dimension as hospitals and imaging networks increasingly evaluate AI reconstruction, photon-counting CT, automation and portable imaging. AI-enabled reconstruction is expected to be the most rapidly adopted Level-2 category because it can increase scanner throughput, improve image quality and extend the productive life of installed hardware without requiring every site to undertake full platform replacement.
CHAPTER 7 - Regional Analysis
Regional Analysis
Australia occupies a high-value position among advanced Asia-Pacific and comparable OECD medical-imaging markets, supported by high equipment density, universal health-system reimbursement and mature hospital infrastructure. Its installed CT, MRI and PET equipment intensity is substantially above the OECD average.
Focus Country Ranking
2nd
Focus Country Market Size
USD 1,030 Mn
Australia CAGR (2025-2032)
6.20%
Focus Country Ranking
2nd
Focus Country Market Size
USD 1,030 Mn
Australia CAGR (2025-2032)
6.20%
Regional Analysis (Current Year)
Market Position
Australia ranks second within the selected peer set, behind Japan, with a 2025 equipment market of USD 1,030 Mn and one of the OECD's highest advanced-imaging equipment densities.
Growth Advantage
Australia's 6.20% modeled CAGR exceeds Canada's reported 2.60% and is broadly comparable with Japan's approximately 5.91%, reflecting stronger MRI reimbursement reform and replacement-cycle momentum.
Competitive Strengths
Australia combines USD PPP 7,469 health spending per capita with 94 CT, MRI and PET systems per million people, supporting premium replacement demand and technology-led procurement.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Challenges & Opportunities
Comprehensive analysis of key factors shaping the Australia Medical Imaging Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Rising Diagnostic Imaging Utilisation
- More than 27 million services (2022-23, Australia) were Medicare-subsidised diagnostic imaging procedures, demonstrating substantial recurring utilisation across radiography, ultrasound, CT, MRI and nuclear medicine.
- Approximately 39% of Australians (2022-23, Australia) received at least one Medicare-subsidised diagnostic imaging service, widening the revenue base for imaging networks and equipment vendors.
- Australian CT examination rates increased by more than 50% (2013-2023, Australia), reinforcing demand for higher-throughput CT platforms and replacement of ageing scanners.
Ageing Population and Disease Burden
- Cancer diagnoses increased from around 88,000 in 2000 to approximately 170,000 cases (2025, Australia), creating sustained demand for CT, MRI, PET and image-guided treatment planning.
- Australian hospitals recorded approximately 12.8 million hospitalisations (2024-25, Australia), maintaining high imaging demand across emergency, surgical, oncology and inpatient pathways.
- The health system included 704 public hospitals (2023-24, Australia), creating a broad institutional procurement base for fixed and mobile diagnostic imaging equipment.
MRI Reimbursement and Medicare Reform
- Partial and previously ineligible MRIs at practices holding existing licences became fully eligible from 1 July 2025 (Australia), raising potential scanner utilisation.
- Subject to legislation, MRI equipment licensing is scheduled for removal from 1 July 2027 (Australia), potentially reducing a structural barrier to new installations.
- Diagnostic imaging MBS indexation for ultrasound, CT, radiology and MRI increased by 2.4% from July 2025 (Australia), supporting provider economics amid equipment and labour cost inflation.
Market Challenges
Medical Imaging Workforce Constraints
- Medical diagnostic radiography is identified as a shortage occupation (2025, Australia), increasing recruitment costs and making automated positioning and reconstruction economically valuable.
- High scanner density of 94 advanced systems per million people (2023 or nearest year, Australia) means workforce availability can become a binding productivity constraint rather than hardware availability alone.
- Workforce scarcity shifts procurement toward automation, remote applications support and systems capable of standardized protocols, increasing vendor differentiation around workflow rather than image quality alone. 30.0 million imaging services (2024-25, Australia) intensify this requirement.
High Import Dependence and Capital Exposure
- CT scanner imports alone totaled approximately USD 113 million (2024, Australia), showing material reliance on overseas high-value equipment manufacturing.
- The United States supplied approximately USD 129 million (2024, Australia) of HS 9022 equipment, while Germany supplied about USD 94 million, concentrating procurement exposure among major manufacturing origins.
- Imported capital intensity increases the importance of multi-year service agreements and lifecycle financing because hospitals must manage equipment refreshes alongside software, detector and magnet-related costs. USD 449 million of HS 9022 imports (2024, Australia) illustrates the scale of exposure.
Regulatory and Digital Compliance Complexity
- Australia's medical-device framework requires registration, classification and conformity assessment under the Medical Devices Regulations 2002, affecting time-to-market and evidence requirements.
- Mandatory UDI compliance starts with Class III and IIb devices on 1 July 2026 (Australia), increasing data-governance and traceability requirements for manufacturers and sponsors.
- The TGA's AI-enabled device register was updated through 27 July 2026 (Australia), reinforcing the need for imaging-software suppliers to integrate clinical, regulatory and post-market evidence processes.
Market Opportunities
AI-Enabled Workflow and Reconstruction
- Vendors can monetize AI through equipment bundles, upgrade licences and recurring software agreements, particularly where scanner throughput is constrained by workforce shortages. Medical diagnostic radiographers were shortage-listed in 2025.
- Hospitals and diagnostic networks benefit where reconstruction reduces scan times or repeat examinations, improving asset productivity across an installed base of 94 advanced scanners per million population.
- Commercial scaling requires ARTG compliance and transparent clinical validation as the TGA continues updating its AI-enabled device list, including entries reported after March 2025.
Regional MRI and Advanced Imaging Expansion
- Investors and radiology operators can target underserved catchments using smaller-footprint MRI and managed-equipment models as licensing constraints reduce after 2027.
- Regional healthcare received a federal package of approximately USD-equivalent public funding supported by AUD 213.6 million (2024-25 policy package, Australia) for medicines, scans and related access initiatives.
- Opportunity realization requires radiographer recruitment, remote specialist reporting and equipment-service coverage, making integrated hardware, software and support contracts more attractive than standalone scanner sales.
Premium Replacement and Photon-Counting CT
- OEMs can capture higher revenue per replacement through photon-counting, spectral imaging and advanced reconstruction rather than competing solely on equipment price. CT imports reached USD 113 million (2024, Australia).
- Hospitals benefit from upgrades that improve diagnostic confidence and throughput while reducing repeat imaging, important in a system handling approximately 12.8 million hospitalisations (2024-25, Australia).
- Procurement models must shift from upfront capital comparisons to total lifecycle economics covering uptime, energy, software, detector replacement and workflow productivity, particularly as advanced technologies command premium acquisition prices.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Competition is concentrated among global imaging OEMs with established Australian service networks, although modality specialists remain important in ultrasound, mammography, digital radiography and emerging premium imaging systems.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
GE HealthCare | - | Chicago, United States | 2023 | CT, MRI, ultrasound, molecular imaging, X-ray and imaging software |
Siemens Healthineers | - | Erlangen, Germany | 2017 | CT, MRI, molecular imaging, X-ray and advanced imaging software |
Philips | - | Amsterdam, Netherlands | 1891 | MRI, CT, radiography, ultrasound and enterprise imaging |
Canon Medical Systems | - | Otawara, Japan | - | CT, MRI, ultrasound, angiography and healthcare IT |
Fujifilm | - | Tokyo, Japan | 1934 | Digital radiography, CT, MRI, ultrasound and PACS |
Hologic | - | Marlborough, United States | 1985 | Mammography, breast imaging and image-analysis software |
Mindray | - | Shenzhen, China | 1991 | Diagnostic and point-of-care ultrasound systems |
Carestream Health | - | Rochester, United States | 2007 | Digital radiography, mobile X-ray and imaging workflow |
Esaote | - | Genoa, Italy | 1982 | Ultrasound, dedicated MRI and imaging IT |
United Imaging Healthcare | - | Shanghai, China | 2011 | CT, MRI, molecular imaging and digital imaging platforms |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Installed Imaging System Base
Service Network Coverage
Australia Imaging Revenue Growth
Lifecycle Service Revenue Mix
Analysis Covered
Market Share Analysis:
Evaluates modality-specific competitive positions across Australian imaging equipment categories.
Cross Comparison Matrix:
Benchmarks installed base, service coverage, revenue growth and mix.
SWOT Analysis:
Assesses technology strengths, channel gaps, regulatory risks and opportunities.
Pricing Strategy Analysis:
Compares capital pricing, lifecycle contracts, upgrades and managed services.
Company Profiles:
Reviews portfolios, positioning, Australian presence and technology differentiation strategies.
CHAPTER 10 - REPORT TOC
Table of Contents
Phase 1Market Assessment Phase
11
Chapters
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Phase 2Go-To-Market Strategy Phase
15
Chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Medicare diagnostic imaging utilisation analysis
- TGA imaging device registration review
- Medical equipment trade flow assessment
- Hospital imaging capacity benchmark analysis
Primary Research
- Radiology department directors interviewed
- Medical imaging procurement managers interviewed
- OEM imaging sales leaders interviewed
- Diagnostic network operations managers interviewed
Validation and Triangulation
- 286 respondents across imaging ecosystem
- OEM and provider estimates reconciled
- Trade and utilisation anchors compared
- Forecast assumptions independently stress-tested
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
- New Zealand Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
- Japan Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
- Kuwait Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
- Philippines Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
- Thailand Medical Imaging Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
- Mexico Medical Imaging Equipment Market
- Thailand Healthcare IT Solutions Market
- Egypt Telemedicine Services Market
- Saudi Arabia Radiology Information Systems Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030
- Saudi Arabia clinical decision support systems market report size, share, growth drivers, trends, opportunities & forecast 2025–2030
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals